Rheumatoid arthritis

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

Arthur Kavanaugh, Philip J Mease, Juan J Gomez-Reino, Adewale O Adebajo, Jürgen Wollenhaupt, Dafna D Gladman, Eric Lespessailles, Stephen Hall, Marla Hochfeld, ChiaChi Hu, Douglas Hough, Randall M Stevens, Georg Schett

10.1136/annrheumdis-2013-205056

March 4, 2014

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

Gerd-Rűdiger Burmester, Alan J Kivitz, Hartmut Kupper, Udayasankar Arulmani, Stefan Florentinus, Sandra L Goss, Suchitrita S Rathmann, Roy M Fleischmann

10.1136/annrheumdis-2013-204769

February 18, 2014

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Joachim Sieper, Jürgen Braun, Jonathan Kay, Salvatore Badalamenti, Allen R Radin, Lixia Jiao, Stefano Fiore, Tanya Momtahen, George D Yancopoulos, Neil Stahl, Robert D Inman

10.1136/annrheumdis-2013-204963

February 18, 2014

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

Frank Behrens, Paul P Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W Huizinga, Vadym Y Berenfus, Stoyanka Vladeva, Juergen Rech, Andrea Rubbert-Roth, Mariusz Korkosz, Dmitriy Rekalov, Igor A Zupanets, Bo J Ejbjerg, Jens Geiseler, Julia Fresenius, Roman P Korolkiewicz, Arndt J Schottelius, Harald Burkhardt

10.1136/annrheumdis-2013-204816

February 17, 2014

Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry

Jan Sørensen, Merete Lund Hetland

10.1136/annrheumdis-2013-204867

February 17, 2014

Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study

Zhaohui Zhu, Yufeng Yin, Kun Zheng, Fang Li, Xiaoyuan Chen, Fengchun Zhang, Xuan Zhang

10.1136/annrheumdis-2013-204820

February 14, 2014

Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study

D Prieto-Alhambra, M K Javaid, A Judge, J Maskell, C Cooper, N K Arden, Mark Mullee, James Rafferty, Andrew Carr, Andrew Price, Kassim Javaid, David Beard, Douglas Altman, Nicholas Clarke

10.1136/annrheumdis-2013-204043

January 22, 2014

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

Clifton O Bingham III, Warren Rizzo, Alan Kivitz, Azra Hassanali, Ruchi Upmanyu, Micki Klearman

10.1136/annrheumdis-2013-204427

January 21, 2014

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

P Emery, J E Gottenberg, A Rubbert-Roth, P Sarzi-Puttini, D Choquette, V M Martínez Taboada, L Barile-Fabris, R J Moots, A Ostor, A Andrianakos, E Gemmen, C Mpofu, C Chung, L Hinsch Gylvin, A Finckh

10.1136/annrheumdis-2013-203993

January 17, 2014

Chronicity of rheumatoid arthritis affects the responsiveness of physical function, but not of disease activity measures in rheumatoid arthritis clinical trials

Daniel Aletaha, Farideh Alasti, Josef S Smolen

10.1136/annrheumdis-2013-204015

January 15, 2014